[go: up one dir, main page]

IE45770L - Pharmaceutical dosage forms - Google Patents

Pharmaceutical dosage forms

Info

Publication number
IE45770L
IE45770L IE187777A IE187777A IE45770L IE 45770 L IE45770 L IE 45770L IE 187777 A IE187777 A IE 187777A IE 187777 A IE187777 A IE 187777A IE 45770 L IE45770 L IE 45770L
Authority
IE
Ireland
Prior art keywords
water
carrier
pharmaceuticals
chemicals
mould
Prior art date
Application number
IE187777A
Other versions
IE45770B1 (en
Original Assignee
John Wyeth
Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB41483/76A external-priority patent/GB1548022A/en
Application filed by John Wyeth, Brother Ltd filed Critical John Wyeth
Publication of IE45770L publication Critical patent/IE45770L/en
Publication of IE45770B1 publication Critical patent/IE45770B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Container Filling Or Packaging Operations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The carrier disintegrates within at most ten seconds in water and has a chemical- and/or pharmaceutical-containing matrix having an open network. This consists of a water-soluble or water-dispersible and/or pharmaceutically tolerable excipient which is inert to the chemicals or pharmaceuticals. The carrier can be prepared by subjecting a solution of the excipient which contains the chemicals or pharmaceuticals to freeze-drying in a mould. This method can be carried out advantageously in a mould which consists of a film having appropriate depressions. After formation of the pill-like carrier, a covering film is stuck on and a finished pack is obtained at the same time. The product according to the invention has the advantage of an administration of medicaments which is more pleasant for the user. [FR2366835A1]
IE187777A 1976-10-06 1977-09-12 Pharmaceutical dosage forms IE45770B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB41483/76A GB1548022A (en) 1976-10-06 1976-10-06 Pharmaceutial dosage forms
GB3039977 1977-07-20

Publications (2)

Publication Number Publication Date
IE45770L true IE45770L (en) 1978-04-06
IE45770B1 IE45770B1 (en) 1982-11-17

Family

ID=26260429

Family Applications (1)

Application Number Title Priority Date Filing Date
IE187777A IE45770B1 (en) 1976-10-06 1977-09-12 Pharmaceutical dosage forms

Country Status (12)

Country Link
JP (1) JPS5344619A (en)
AU (1) AU513845B2 (en)
CH (1) CH633717A5 (en)
CY (1) CY1129A (en)
DE (1) DE2744493A1 (en)
FR (1) FR2366835A1 (en)
HK (1) HK58081A (en)
IE (1) IE45770B1 (en)
KE (1) KE3171A (en)
LU (1) LU78259A1 (en)
MY (1) MY8200187A (en)
NL (1) NL189898C (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455459A1 (en) * 1979-05-02 1980-11-28 Sertog Carboxy:methylcellulose matrix for slow release of volatile cpd. - contains tri:ethanolamine, stearin and an alcohol e.g. cetyl is esp. useful for perfumes, insect repellents eczema treatment etc.
IE53696B1 (en) * 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
AT385200B (en) * 1986-07-22 1988-02-25 Kwizda Fa F Johann Process for the production of tablets with delayed release characteristics of medicinal substances
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4771077A (en) * 1986-10-21 1988-09-13 American Home Products Corporation (Del.) Spray dried acetaminophen
US4767789A (en) * 1986-10-21 1988-08-30 American Home Products Corporation (Del.) Spray dried acetaminophen
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
FR2634376B1 (en) 1988-07-21 1992-04-17 Farmalyoc NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION
JPH02247447A (en) * 1989-03-17 1990-10-03 Matsushita Refrig Co Ltd Control method for air conditioner
FR2647343B1 (en) * 1989-05-24 1994-05-06 Rhone Poulenc Sante NOVEL POROUS PHARMACEUTICAL FORM AND ITS PREPARATION
JPH0331644A (en) * 1989-06-28 1991-02-12 Matsushita Refrig Co Ltd Air conditioner control device
FR2657258A1 (en) 1990-01-19 1991-07-26 Farmalyoc NOVEL UNITARY, SOLID, POROUS FORM COMPRISING PARTICLES IN THE FORM OF PEARLS AND ITS PREPARATION.
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
ES2087558T3 (en) * 1991-12-20 1996-07-16 Pfizer POROUS CONFORMED MEANS OF ADMINISTRATION AND THEIR PRODUCTION PROCEDURE.
NZ246091A (en) 1991-12-24 1995-08-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation containing an active ingredient, agar, and lactose and/or mannitol
DE4221880A1 (en) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Solid and liquid solutions of poorly water-soluble drugs
DE4342091A1 (en) * 1993-12-09 1995-06-14 Asta Medica Ag Products for the application of initially high doses of Cetrorelix and manufacture of a combination pack for use in the treatment of diseases
KR100330942B1 (en) * 1994-03-02 2002-11-16 악조 노벨 엔.브이. Sublingual or buccal pharmaceutical composition
GB9421836D0 (en) * 1994-10-28 1994-12-14 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms of hydrophobic substances
US5738875A (en) * 1994-10-28 1998-04-14 R.P. Scherer Corporation Process for preparing solid pharmaceutical dosage forms
GB9504201D0 (en) 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
DK0914818T3 (en) 1996-06-14 2005-07-04 Kyowa Hakko Kogyo Kk Intraoral fast disintegrable tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
GB9717770D0 (en) * 1997-08-21 1997-10-29 Scherer Ltd R P Pharmaceutical composition
ATE215820T1 (en) * 1997-10-08 2002-04-15 Sepracor Inc DOSAGE FORM FOR ADMINISTRATION OF AEROSOLS
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
GB9722682D0 (en) * 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP4173670B2 (en) * 2002-03-08 2008-10-29 旭化成ファーマ株式会社 Orally disintegrating preparation
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
PL210707B1 (en) * 2003-02-28 2012-02-29 Alk Abello As Dosage form having a saccharide matrix
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
WO2006047493A2 (en) 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20080031944A1 (en) * 2006-08-04 2008-02-07 Cima Labs Inc. Stabilization of lorazepam
CN102958515A (en) 2009-12-02 2013-03-06 阿普塔利斯制药有限公司 Fexofenadine microcapsules and compositions containing them
JP2012121850A (en) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd Oral fast-dissolving composition of aripiprazole
JP2015172084A (en) * 2015-07-06 2015-10-01 大塚製薬株式会社 Quickly-soluble oral composition of aripiprazole
JP6572257B2 (en) * 2017-05-16 2019-09-04 大塚製薬株式会社 Aripiprazole oral fast-dissolving composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166074A (en) * 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
GB836811A (en) * 1955-07-08 1960-06-09 Ciba Ltd Shaped medicament carriers and process for their manufacture
GB1083896A (en) * 1964-04-30 1967-09-20 Dunster Lab Ltd Vehicles for administering drugs
DE2017373A1 (en) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophilized products and processes for their manufacture
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
DE2246013A1 (en) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh PROCESS FOR THE MANUFACTURING OF POROUS TABLETS
DE2556561C2 (en) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Process for the production of porous tablets

Also Published As

Publication number Publication date
LU78259A1 (en) 1978-06-09
JPS5344619A (en) 1978-04-21
FR2366835A1 (en) 1978-05-05
IE45770B1 (en) 1982-11-17
MY8200187A (en) 1982-12-31
NL189898B (en) 1993-04-01
FR2366835B1 (en) 1980-10-24
NL189898C (en) 1993-09-01
NL7710876A (en) 1978-04-10
CY1129A (en) 1982-02-19
DE2744493C2 (en) 1991-07-18
HK58081A (en) 1981-12-04
AU2882577A (en) 1979-03-22
DE2744493A1 (en) 1978-04-13
AU513845B2 (en) 1981-01-08
KE3171A (en) 1981-12-18
CH633717A5 (en) 1982-12-31
JPS6250445B2 (en) 1987-10-24

Similar Documents

Publication Publication Date Title
IE45770L (en) Pharmaceutical dosage forms
NO175564C (en) Process for the preparation of an oral, osmotic acting system for heavily soluble therapeutics
ATE101340T1 (en) NEW DRUG FORMULATION AND METHOD OF PRODUCTION.
EP0395329A3 (en) composition in the form of a foam containing 5-aminosalicylic acid for intra-rectal administration
FR2273515A1 (en) PROCESS FOR MANUFACTURING A MONOLITHIC BODY FOR THE CONTINUOUS RELEASE OF ACTIVE AGENTS, IN PARTICULAR MEDICINAL PRODUCTS
NL7903421A (en) N-SUBSTITUTED MORANOLINE DERIVATIVES, METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT THEREOF, AND THE MEDICINAL PRODUCT THEREOF.
NL183032C (en) METHOD FOR PREPARING PHARMACEUTICALLY ACTIVE N-SUBSTITUTED 4,5,6,7-TETRAHYDROTHIENO-PYRIDINE DERIVATIVES, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AND PHARMACEUTICAL ARTICLE.
NL960028I1 (en) ML-236B derivatives, process for their preparation and pharmaceutical preparations containing these derivatives.
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
NL181006B (en) METHOD FOR THE PREPARATION OR MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EPILEPSIA, Dizziness, HYPOKINESIS, SKULL TRAUMA AND GERIATRIC DISEASES, AND METHOD FOR THE PREPARATION OF A 4-AMINIVATIC ACID.
IE38602L (en) Aryloxyalkanolamine derivatives
IE882391L (en) Pad printing process
ZA79778B (en) New propanone derivatives,process for producing thereof and pharmaceutical composition containing this derivative as active ingredient
IE35177L (en) Piperazinyl-uracil derivatives.
NL7416389A (en) METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT SUITABLE FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF ACUTE HYPERSENSITIVITY DISEASES, FORMED MEDICINAL PRODUCT AND METHOD FOR PREPARING MEDICINAL COMPOUNDS.
NL164472B (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION SUITABLE FOR ORAL ADMINISTRATION, SUITABLE FOR THE TREATMENT OF OESOPHAGITIS AND ARTICLES OBTAINED THEREOF.
IE42950L (en) X-ray contrast preparations
CA990165A (en) Implant for directed infusion of biologically active substances, a method for its producing and a mold for carrying out said method
FR2334345A1 (en) NEW BENZYL ALCOHOL DERIVATIVE, ITS PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING IT
NL7704456A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICALLY ACTIVE PHENYLPIPERAZINS, PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION AND PREPARATION, OBTAINED BY THIS PROCESS.
NL180431B (en) PROCESS FOR CONTINUOUS POLYMERIZATION OF EPSILON CAPROLACTAM AND FORMED PREPARATION PREPARED USING A PREPARED POLY-EPSILON CAPROLACTAM.
CA962588A (en) Method, apparatus, and fungicides for the treatment of trees subject to dutch elm disease and other fungus diseases
NL152859B (en) METHOD OF PREPARING A MEDICINAL PRODUCT FOR HEART DISEASES AND THE OBTAINED PREPARED MEDICINAL PRODUCT AND FOR PREPARING A PROCESS SUITABLE FOR INCLUDING IN SUCH MEDICINAL PRODUCT 1-AMINO-3-CHROMAN-2-AMINO-3-CHROMAN.
ES8603262A1 (en) Oral solid pharmaceutical form with sequential action for the administering of drugs with ulcerogenic side effect.
NL179053C (en) N-SUBSTITUTED MORANOLINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, AND METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH SUCH DERIVATIVE THEREIN.

Legal Events

Date Code Title Description
MK9A Patent expired